Follow The Filings

LOVE Lovesac

Lovesac earnings company data as of 4:51 AM ET 10/23

  • 0 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q4 10 Dec EPS — — —
Rev — — —
FY2027 Q2 10 Sep EPS -0.13 -1.19 Miss
Rev $162.4M $161.2M Miss -0.7%

Insider trades

Open-market buys and sales by LOVE's executives, directors and 10% owners in the last 12 months, from their Form 4s

All LOVE insider trades
  • $515K bought by 3 insiders
  • $92K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Vineet Mehra Director
    Sale
    $92K 5,000 shares at $18.38 22% of stake
    Traded Jul 17 Filed Jul 17
    ↗
  2. Shawn David Nelson CEO
    Buy
    $25K 1,830 shares at $13.64 +0.9% to stake
    Traded Jun 22 Filed Jun 23
    ↗
  3. Mary Fox President
    Buy
    $25K 1,720 shares at $14.41 +2.5% to stake
    Traded Jun 22 Filed Jun 22
    ↗
  4. Andrew R Heyer Director
    Buy
    $440K 30,000 shares at $14.68 +11% to stake
    Traded Jun 18 Filed Jun 22
    ↗
  5. Shawn David Nelson CEO
    Buy
    $25K 1,477 shares at $16.95 +0.7% to stake
    Traded Apr 16 Filed Apr 20
    ↗
  6. Shawn David Nelson CEO
    Buy
    $14K 1,000 shares at $14.41 +0.6% to stake
    Traded Oct 14, 2025 Filed Oct 14, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 17 share withholdings for taxes, 14 option exercises, 12 stock grants, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A DEFINITIVE PROXY STATEMENT Filing Doc
DEFA14A DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS Filing Doc
10-K Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.